Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 45% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 3 institutions in 2 countries.
Pedro Martín-AcostaInstituto Universitario de Bio-Orgánica Antonio González. Departamento de Química Orgánica. Universidad de La Laguna Avda. Astrofísico Fco. Sánchez N° 2, 38206 La Laguna, Spain.
Rosalyn PeñaInstituto Universitario de Bio-Orgánica Antonio González. Departamento de Química Orgánica. Universidad de La Laguna Avda. Astrofísico Fco. Sánchez N° 2, 38206 La Laguna, Spain.
Gabriela FeresinInstituto de Biotecnología-Instituto de Ciencias Básicas, Universidad Nacional de San Juan, Av. Libertador General San Martín 1109 (O), CP 5400 San Juan, Argentina.ORCID 0000-0002-4076-3999
Alejandro TapiaInstituto de Biotecnología-Instituto de Ciencias Básicas, Universidad Nacional de San Juan, Av. Libertador General San Martín 1109 (O), CP 5400 San Juan, Argentina.
Isabel Lorenzo-CastrillejoUnidad de Investigación Hospital Universitario Nuestra Señora de La Candelaria, 38010 Santa Cruz de Tenerife, Spain.
Félix MachínUnidad de Investigación Hospital Universitario Nuestra Señora de La Candelaria, 38010 Santa Cruz de Tenerife, Spain.ORCID 0000-0003-4559-7798
Ángel AmestyInstituto Universitario de Bio-Orgánica Antonio González. Departamento de Química Orgánica. Universidad de La Laguna Avda. Astrofísico Fco. Sánchez N° 2, 38206 La Laguna, Spain.
Ana Estévez-BraunInstituto Universitario de Bio-Orgánica Antonio González. Departamento de Química Orgánica. Universidad de La Laguna Avda. Astrofísico Fco. Sánchez N° 2, 38206 La Laguna, Spain.ORCID 0000-0001-5279-7099
Universidad de La Laguna · ESNational University of San Juan · ARHospital Universitario Nuestra Señora de Candelaria · ES
Funding
Agencia Canaria de Investigación, Innovación y Sociedad de la Información ProID2017010071, ProID2017010167Ministerio de Ciencia, Innovación y Universidades RTI2018-094356-B-C21, BFU2017-83954-R
6 · The paper itself
Abstract
A library of embelin derivatives has been synthesized through a multicomponent reaction from embelin (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Efficient Multicomponent Synthesis of Diverse Antibacterial Embelin-Privileged Structure Conjugates. · full record | OpenQuestion